Journal Image
Current Drug Safety
ISSN (Print): 1574-8863
ISSN (Online): 2212-3911
DOI: 10.2174/157488606777934404      Price:  $58

NSAID Use and the Risk of Parkinsons Disease

Author(s): Mahyar Etminan and Samy Suissa
Pages 223-225 (3)
Parkinsons disease (PD) is a neurodegenerative disease with limited pharmacologic therapies. Recent animal studies and one large retrospective study have found NSAIDs to be protective against the development of PD. We decided to test this hypothesis by conducting a nested case-control study using the Saskatchewan drug plan database. Entry to the cohort was defined as the first prescription of an antihypertensive agent between 1980 and 1987 and followed until 1999. Cases were defined as those having received three prescriptions for a dopamine agonist within a year. For each case, ten controls were selected matched to the case by age, calendar time and index date. Conditional logistic regression was used to estimate rate ratios adjusting for gender, previous use of arthritis medication and previous antipsychotic use. Current users of NSAIDs had a slightly higher risk of developing PD (RR= 1.49 [95% CI, 1.11-2.01]). This effect was not seen with past users (RR= 1.18 [95% CI, 0.89-1.59]). Based on the results of our study current users of NSAIDs may be at a slightly higher risk of developing PD. More studies are needed to confirm this finding.
NSAIDsd, Parkinson's disease
Center for Clinical Epidemiology and Evaluation, Vancouver Hospital, 7th Floor - 828 W. 10th Ave., Vancouver, BC, Canada V5Z 1L8.